Sub-I
Chungnam National University Hospital, Republic of Korea
JaeHoon Kim has been conducting more than 10 new clinical trials every year on average, as a Sub-investigator more than 4 years.These trials involve drugs and biologic products regarding a wide range of therapeutic areas, and span over various kinds of trial types such as first-in-human (FIH) studies, pharmacokinetic-pharmacodynamic studies, drug-drug interaction (DDI) studies, new formulation evaluations, clinical pharmacogenomic (PGx) studies, and bioequivalence /bioavailability (BE/BA) studies. He is currently a PhD student of Department of Clinical Pharmacology and Therapeutics at Chungnam National University Hospital Clinical Trials Center.